Blood samples collection
Other50 mL blood sample
NCT Number: NCT06451744
Lichen planus (LP) is a chronic inflammatory disease of unknown aetiology, affecting the skin and mucous membranes, characterised by a CD8+ cytotoxic T-cell infiltrate, associated with epithelial cell death and disruption of the basement membrane zone. In previous work, T cell antigen receptor (TCR) repertoire studies were performed. In all patients tested, whether with erosive or non-erosive LP, unique nucleotide sequences, called clonotypes, have been identified. They appear during the process of TCR gene rearrangement. These clonotypes are specific for human papillomavirus (HPV) in blood and lesions, suggesting antigenic stimulation of these clonotypes by a viral epitope of HPV, which crosses with an epitope on keratinocytes. The diagnosis of LP is made on the basis of clinical and histological criteria, but in some patients and in some anatomical locations, the diagnosis is difficult to make and LP may be confused with other skin conditions.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
CHU de Besançon, Besançon, France
Lichen planus (LP) is a chronic inflammatory disease of unknown aetiology, affecting the skin and mucous membranes, characterised by a CD8+ cytotoxic T-cell infiltrate, associated with epithelial cell death and disruption of the basement membrane zone. Several triggers have been proposed for LP, including viral antigens. In previous work, T cell antigen receptor (TCR) repertoire studies were performed, i.e. investigating the diversity of TCRs expressed on the surface of an individual's lymphocyte population. In all patients tested, whether with erosive or non-erosive LP, unique nucleotide sequences, called clonotypes, have been identified. They appear during the process of TCR gene rearrangement. These clonotypes are specific for human papillomavirus (HPV) in blood and lesions, suggesting antigenic stimulation of these clonotypes by a viral epitope of HPV, which crosses with an epitope on keratinocytes. The diagnosis of LP is made on the basis of clinical and histological criteria, but in some patients and in some anatomical locations, the diagnosis is difficult to make and LP may be confused with other skin conditions.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
50 mL blood sample
brushing on skin or mucous membrane lesions
6 mm biopsy
Time frame: 3 years
Determination by flow cytometry and PCR testing for TCR repertoire bias
Time frame: 3 years
Identify complementary biomarkers characterising lichen by quantitative PCR
Time frame: 3 years
Measurement of the antigenic specificity of identified T CD8 clonotypes by flow cytometry
Contact information is provided by the study sponsor or research team.
Marie-Lise Gougeon
CONTACT
Sandrine Fernandes Pellerin
CONTACT
Institut Pasteur
Industry
Evaluation of the Clinical Specificity of Cellular and Molecular Biomarkers Identified in Patients With Lichen Planus
Acronym: HELP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06599411
Active Leprosy, Atopic Dermatitis
Paris, France
View Trial DetailsNCT05928169
Alopecia, Alopecia Areata
Kiel, Germany
View Trial DetailsNCT07570706
Lichen Planus, Lichenoid Eruptions
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT00542373
Anemia, Anemia, Aplastic
Houston, Texas, United States
View Trial Details